Malta - angļu - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - imipramine hydrochloride - coated tablet - imipramine hydrochloride 25 mg - psychoanaleptics

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

geigy pharmaceuticals - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - injection, solution - 25 mg in 2 ml - depression : for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. initial dosage should be low and increases should be gradual and cautiously prescribed. the drug is contraindicated during the acute recovery period after a myocardial infarction. patients with a known hypersensitivity to this compound should not be given the drug. the possibility of cross-sensitivity to other dibenzazepine compounds should be k

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride, quantity: 10 mg - tablet, sugar coated - excipient ingredients: macrogol 8000; povidone; stearic acid; hypromellose; purified talc; glycerol; magnesium stearate; titanium dioxide; maize starch; microcrystalline cellulose; iron oxide red; colloidal anhydrous silica; lactose monohydrate; sucrose; copovidone - major depression. nocturnal enuresis (from the age of 5 years onwards and provided the possibility of organic causes has first been excluded).

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride, quantity: 25 mg - tablet, sugar coated - excipient ingredients: titanium dioxide; microcrystalline cellulose; colloidal anhydrous silica; sucrose; magnesium stearate; stearic acid; lactose monohydrate; hypromellose; maize starch; glycerol; povidone; iron oxide red; macrogol 8000; carnauba wax; purified talc; copovidone - major depression. nocturnal enuresis (from the age of 5 years onwards and provided the possibility of organic causes has first been excluded).

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential pharma ltd - imipramine hydrochloride - oral solution - 5mg/1ml

Kanāda - angļu - Health Canada

d.c. labs limited - imipramine hydrochloride - tablet - 25mg - imipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanāda - angļu - Health Canada

d.c. labs limited - imipramine hydrochloride - tablet - 50mg - imipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Kanāda - angļu - Health Canada

aa pharma inc - imipramine hydrochloride - tablet - 25mg - imipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors